Literature DB >> 17823188

Should terminally ill patients have the right to take drugs that pass phase I testing? No.

Dean Gesme1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17823188      PMCID： PMC1971215          DOI： 10.1136/bmj.39245.429525.AD

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  The Society for Clinical Trials opposes US legislation to permit marketing of unproven medical therapies for seriously ill patients.

Authors: 
Journal:  Clin Trials       Date:  2006       Impact factor: 2.486

2.  Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study.

Authors:  N A Christakis; E B Lamont
Journal:  BMJ       Date:  2000-02-19
  2 in total
  3 in total

1.  Right-to-try laws and individual patient "compassionate use" of experimental oncology medications: A call for improved provider-patient communication.

Authors:  Michael Hoerger
Journal:  Death Stud       Date:  2015-08-27

2.  What do patients with unmet medical needs want? A qualitative study of patients' views and experiences with expanded access to unapproved, investigational treatments in the Netherlands.

Authors:  Eline M Bunnik; Nikkie Aarts
Journal:  BMC Med Ethics       Date:  2019-11-09       Impact factor: 2.652

3.  The 'false hope' argument in discussions on expanded access to investigational drugs: a critical assessment.

Authors:  Marjolijn Hordijk; Stefan F Vermeulen; Eline M Bunnik
Journal:  Med Health Care Philos       Date:  2022-08-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.